Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Vasopressin vs. Norepinephrine in Post-CABG Patient with Impella Device

Hemodynamic Considerations with Impella Device

  • The Impella device is a temporary mechanical circulatory support device that increases left ventricular afterload, which can negatively impact cardiac recovery in post-CABG patients 1
  • Narrow pulse pressure from the right radial arterial line suggests a mixing point proximal to the innominate artery, indicating potential hemodynamic compromise 1
  • Low systolic blood pressure in a post-CABG patient with an Impella device indicates the need for vasopressor support to maintain adequate mean arterial pressure (MAP) for cerebral and end-organ perfusion 1, 2

Management Protocol for Vasopressin Administration

  • Monitor mean arterial pressure targeting 70 mmHg to ensure adequate cerebral and end-organ perfusion while minimizing LV afterload 1

Potential Pitfalls and Considerations

  • Vasopressin may cause excessive vasoconstriction if used at high doses, so careful titration is necessary 2
  • Patients with Impella devices require careful anticoagulation management, as there is a higher risk of bleeding complications compared to other support devices 2

REFERENCES

2

Temporary Ventricular Assist Devices with Impella [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025